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Nuclear calcium signaling is initiated by surges in cytosolic calcium in
vascular smooth muscle cells. Calcium is not only a second messenger in
the cytoplasm but also may be involved in signaling within the nucleus
itself. The regulation of the nuclear calcium signal is imperfectly defined.
The purpose of our study was to further elucidate the relationship between
cytosolic [Ca] and nuclear calcium concentration [Ca] in vascular
smooth muscle cells and to test the hypothesis that components of the
phospholipase C-induced signaling system are responsible for the hor-
mone-induced increase in [Ca]0. Cytosolic [Ca] and nuclear calcium
concentration [Ca] were measured by confocal microscopy in primar-
ily cultured vascular smooth muscle cells from rat aorta. Basal [Ca]
was lower than the cytosolic calcium [Ca concentration. Angiotensin
II (10 M) induced a rapid increase in [Ca] which was immediately
followed by a surge in [Ca The high [Ca' ], was maintained for 20
to 30 seconds and returned to basal values thereafter. Increased trans-
membraneous calcium influx by KCI (80 mM) led to a rapid rise in
[Ca]. Treatment of vascular smooth muscle cells with ionomycin (10
M) also induced an increase in [Ca] accompanied by an increase in
[Ca' The calcium channel agonist A 2386 led to a slower increase in
both [Ca'] and [Ca]. An increase in extracellular calcium to 6 mM
under these conditions enhanced the surge of [Ca] but not [Ca].
Removal of extracellular calcium by EGTA decreased both the angioten-
sin Il-induced increase in [Ca] and the increase in [Ca]. Nitren-
dipine (10- M) had the same effect as EGTA. Inhibition of the intracel-
lular release by preincubating vascular smooth muscle cells with
thapsigargin (10' M) also partially inhibited the effect of angiotensin II
(Ang H) on [CaJ,,. However, combined EGTA and thapsigargin
abolished both the rise in [Ca and the surge in [Ca The protein
kinase C inhibitors staurosporine (5 X 10—8 M) and H7 (10 M) had no
effect on the Ang 11-mediated increases in [Ca] and [Ca]. Our
results demonstrate that the angiotensin IT-induced increase in [Ca' '] is
rapidly followed by a rise in This effect on [Ca] is not
mediated by an angiotensin 11-induced generation of IF3 or activation of
protein kinases, but rather seems to depend on an increase in [Ca
Hormones and neural transmitters stimulate smooth muscle
contraction by inducing a rise in intracellular free calcium
([Ca High resolution digital imaging microscopy and mod-
ern fluorescent Ca indicators permit the demonstration that
hormonal activation induces a localized region of increased
[Ca within the cell, followed by a "calcium wave" which may
drive the propagation of contraction [1, 2]. Ca + may also be
important for nuclear signaling. The initiation of gene transcrip-
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tion and cell cycle events are linked to increases in [Ca]1. For
instance, an increase in [Cat triggers nuclear envelope break-
down in the sea urchin embryo and is a prerequisite for the
initiation of mitosis in these cells [3]. Using fluorescent probes,
several authors have shown that nuclear calcium concentration
([Ca k],,) is different compared to cytosolic calcium concentra-
tion ([Cat Himpens et al [2] used the fluorescent dye indo-1
and the confocal laser microscope to demonstrate differences in
regulation between [Ca] and [Ca] in cultured smooth
muscle cells. They found that [Cat values were lower than
[Ca concentrations in resting cells. However, when the cells
were stimulated with histamine, they observed a striking increase
in [Ca k],, values which exceeded those in the cytosol. Using a
different cell line, namely the LLC-PK1 cells, these investigators
then examined a variety of agonists and again observed differen-
tial increases in [Cat ] as well as situations in which [Cat
values exceeded [Cat concentrations [4, 5]. The existence of a
Ca ÷ gradient between the nucleus and the cytosol has also been
observed by others [6—li]. Himpens et al [2] and others [7, 8] have
suggested that a specific regulation of [Ca may be important
in gene expression or cell proliferation. However, the mechanisms
of how [Cat concentrations are regulated are unclear. It has
been proposed that Ca may be released in the nucleus as in
other cellular compartments by inositol phosphates, namely 1P3
[7]. In fact, 1P3 receptors have been described in isolated nuclei
[12, 13]. Nicotera et al have observed an ATP-dependent Ca
uptake in hepatic nuclei [14]. Others have suggested a Ca -
triggered Ca release [8]. The purpose of our studies was to
further elucidate the relationship between [Ca and [Ca
in vascular smooth muscle cells. We tested the hypothesis that
components of the phospholipase C-induced signaling system,
that is, 1P3, proteinkinase C, and/or the changes in the [Cat
concentration are responsible for the increase in the [Ca]
concentration following hormonal stimulation. Angiotensin (Ang)
II was used as the hormonal stimulus because it acts intracellularly
mainly via the G-protein-induced activation of phospholipase C
(PLC) with the subsequent generation of 1P3, increase in [Cat +]
concentration and activation of protein kinase C (PKC) [15, 16].
We chose Ang II not only because of its known vasopressor
effects, but also because Ang II is associated with hypertophy and
proliferation of vascular smooth muscle cells [17]. We found that
Ang II causes a surge in [Ca++]. Furthermore, our data
demonstrate that [Ca ] is not regulated by an Ang Il-induced
generation of 1P3 or activation of protein kinases. Instead, the
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Fig. 1. Confocal photomicrograph of temporal and spatial changes in [Ca J in single vascular smooth muscle cells after stimulation with angiotensin II
(1O— M). Computer generated color images (blue, green, yellow, red, violet and grey) represent increasing Ca concentrations. The subcellular
distribution of [Ca ]at rest (0), and at 5, 10 and 40 seconds after angiotensin II are shown. In the resting state, the concentrations of Ca + weregreater
in the cytoplasm than in the nucleus. After stimulation, this gradient was reversed; by 10 seconds, the nuclear concentrations peaked at values greater
than anywhere else in the cell. At 40 seconds, the nuclear concentrations had begun to decrease. (Representative experiment Out of 20). Reproduction
of this figure in color is made possible by a grant from Bayer, Leverhusen, Germany.
[Cat propagation wave seems to be dependent on an increase
in [Ca++].
Methods
The fluorescent probe fluo-3 was purchased from Serva (Hei-
delberg, Germany). All other materials, if not stated otherwise,
were purchased from Sigma Chemical Co. (St. Louis, Missouri,
USA). Adult, male Wistar-Kyoto rats were obtained from Fisher
Laboratories. Care of animals was in accord with institutional and
American Physiological Society guidelines.
VSMC cultures
Rat aortic vascular smooth muscle cells (VSMC) were cultured
by previously described procedures modified from Chamley-
Campbell, Campbell and Ross [181 and described by us in detail
elsewhere [19]. Briefly, the rats (12 to 14 weeks old) were killed
instantly and their thoracic aortas were excised. After adherent fat
and connective tissue were removed, the aortas were cut longitu-
dinally and the endothelial cells were removed by gentle scraping
with fine forceps. The aortas were then minced into small pieces
and were incubated at 37°C for two hours in PBS without Ca ,
but with 1 mg/mI collagenase (type I, 150 lU/mg, Worthington
Biochemical Corp., Freehold, New Jersey, USA), 0.5 mg/mI
elastase (type III, 40 lU/mg, Sigma) and 0.5 mg/mI trypsin
inhibitor (Sigma). After two hours, Dulbecco's modified Eagle's
medium (DMEIF-12) containing 10% fetal calf serum (FBS,
Gibco, Eggenstein, Germany) was added to the suspension to
inactivate enzymes. The cells were then centrifuged at 120 g for 10
minutes and the pellet was resuspended in DME/F-12 with 10%
FBS. The cells were then seeded at a density of 3 to 5 X 105/cm2
and were cultured at 37°C in 95% air with 5% CO2. Cells from
passages 2 to 4 were used in all experiments. The phenotype of the
cultured VSMC was determined by staining the cells for a-actin
and desmin. Antibodies for muscle specific cs-actin and desmin
were obtained from Boehringer-Mannheim, Germany.
Calcium imaging with confocal microscopy
For Ca imaging, VSMC were sewn on cover slips and
incubated at 37°C for one to two days. The cells were then loaded
with fluo-3 by a 20-minute incubation in PBS containing 5 jiM
fluo-3-AM (added from a 5 m stock solution in DMSO and 2%
bovine serum albumin) at 37°C. Before the measurements, cells
were rinsed three times with PBS and mounted on a Nikon
Diaphot inverted microscope. Measurements were performed
with a Biorad MRC 600 confocal imaging system (Bio-Rad
Laboratories, Freiburg, Germany) with an argon laser. We used a
Nikon Plan Apo 100 objective with a numerical aperture of 1.4
resulting in a theoretical Z width half maximum of 0.23 jim. As
the optical section depth depends on the confocal aperture, we
selected a small aperture 1.8 mm (range of opening width: 0.7 to
8 mm). We then assessed the Z width half maximum for this
pinhole setting by measuring the distance between maximal and
half-maximal intensitiy of a fluo-3 solution. The measured Zwidth
half maximum was 0.45 jim.
Measurements were performed using the 488 nm wavelength of
an argon laser by time mode and line-scanning mode. Ca -free
conditions were achieved by adding 2.5 mivi EGTA to all solutions.
Ca + values were estimated by adding ionomycin (10—i M) and 6
mM CaCl for dye saturation and EUTA (25 mM) for zero Ca
concentration. Calculation was done according to the equation:[Ca] = kD (Fmax — F)/(F — Fmin) using a kD of 400 flM as
described [20]. F-values were obtained through the BioRad
Comos software, However, these Ca values should be inter-
preted with caution since they are only an estimate that depends
on the calibration conditions used. After exposure to Ang II,
picture frames were recorded in 10 second intervals. At least 10 to
18 cells from each of at least seven separate experiments were
examined for each experimental condition.
Statistics
Since the data feature substantial variability and are not
uniformly distributed, we employed non-parametric statistical
tests, such as the sign test and Mann-Whitney test to analyze the
data from the 7 to 10 separate experiments. A P value <0.05 was
accepted as significant. References to increases or decreases in
the following section are only so stated if statistically significant.
Results
[Ca and [Ca in single cells in response to Ang II
Figure 1 shows a confocal photomicrograph of temporal and
spatial changes in [Ca ] in single vascular smooth muscle cells
after stimulation with Ang II (10—v M). The computer generated
color images (blue, green, yellow, red, violet and grey) represent
increasing [Ca } concentrations. The subcellular distribution of
[Ca] at rest (0), and at 5, 10 and 40 seconds after Ang II is
shown. In the resting state, the [Cat +] concentrations were
greater in the cytoplasm than in the nucleus. After stimulation,
this gradient was reversed, After 10 seconds, the nuclear concen-
trations peaked at values greater than anywhere else in the cell.
This effect was dramatically displayed by the intense white cell
nuclei. At 40 seconds, the nuclear concentrations began to
decrease.
Figure 2 shows the kinetics of the initial temporal and spatial
distribution of [Cat ] in a vascular smooth muscle cell after
stimulation with Ang II in [Cat ]-containing medium. In the left
hand portion, the [Ca]0 concentration in the resting state
within the cell can be seen. The dark nucleus attests to a lower
[Cat value compared to [Cat The cytometer was used in
the line scan mode, where the scanned region was reduced to a
single, confocal line across the cell. The white line through the cell
represents the axis at which the temporal changes in the [Ca]
signal after stimulation were determined. In the right hand
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Fig. 2. Kinetics of the initial temporal and spatial distribution of [Ca] in vascular smooth muscle cells after stimulation with Ang II (1O— M) in
[Ca] -containing medium. In the upper portion, the [Ca] concentration in the resting state within the cell can be seen. The white line through the
cell represents the axis at which the temporal changens in the [Caj signal after stimulation were determined. In the lower portion is shown a graded
colorimetric line scan of the dynamically changing [Ca ÷1 signal through that same axis. Blue, green, yellow, red, violet and grey represent increasing[Ca] concentrations, respectively. The ordinate shows time from 0 to 4.5 seconds. Fluorescence was measured every 1.5 msec for 4.5 seconds through
the axis of the cell and its nucleus before and after stimulation, Shown are the Ang fl-induced increases in both compartments. Following the addition
of Ang H, [Ca]1 first increased in the cytosol. Thereafter the signal moved in both directions to the periphery of the cell and to the nucleus, There
was a steep increase in [Ca] from an initial value of almost zero to very high (>1 rM) concentrations. (Representative experiment out of 8).
Reproduction of this figure in color was made possible by a grant from Bayer, Leverkusen, Germany.
portion, is shown a graded colorimetric line scan of the dynami- stimulation from 0 to 4.5 seconds. Fluorescence was measured
cally changing [Ca] signal through that same axis. Blue, green, every 1.5 msec for 4.5 seconds through the axis of the cell and its
yellow, red, violet and grey represent increasing [Ca ] concen- nucleus before and after stimulation. Shown are the Mg II-
trations, respectively. The ordinate shows the time after Aug II induced increases in both compartments. Following addition of
Fig. 3. Kinetics of the temporal and spatial distribution of [Ca] in a vascular smooth muscle cell after stimulation with Ang II (1O— M) in
[Ca + J-containing medium. The distribution of [Ca ] in the unstimulated, resting cell may be seen in the A. The lowest values are present in the
nucleus. The line represents the axis through which the scan of the [Ca] signal following stimulation was obtained. These line scans were divided in
cytosolic and nuclear domains (C) and an integrated [Ca ] ratio (B) was calculated in each segment for each scan. The temporal axis extends from
0 to 100 seconds, and applies to both the line scans and the calculated [Ca j values. Shown are the Ang Il-induced increase in both compartments.
A small rise in [Ca] was immediately followed by a large surge in [Ca] concentration. Both signals decreased in a parallel fashion to basal values
by 75 seconds (Representative experiment out of 15). Reproduction of this figure in color was made possible by a grant from Bayer, Leverkusen,
Germany.
Ang II, [Ca ] increased first. Thereafter the signal wave moved
in both directions to the periphery of the cell and to the nucleus.
There was a steep increase in [Cat from an initial value of
almost zero to very high (>1 mM) concentrations.
The kinetics of the temporal and spatial distribution of [Ca ]
in vascular smooth muscle cells after stimulation with Ang II in
[Cat ]-containing medium are shown in Figure 3. The distribu-
tion of [Ca ] in the unstimulated resting cell may be seen on the
left. The lowest values are present in the dark nucleus, while
scattered, low concentrations are visible in the cytoplasm. The
cytometer was again used in the line scan mode, where the
scanned region was reduced to a single, confocal line across the
cell. The line again represents the axis through which the scan of
the [Cat ] signal following stimulation was obtained. These line
scans were graphically divided in cytosolic and nuclear domains
(lower right) and an integrated [Ca] ratio (upper right) was
calculated in each segment for each scan. The temporal axis
extends from 0 to 100 seconds, and applies to both the line scans
and the calculated [Cat 1 values. Shown are the Ang Il-induced
increases in both compartments from a single stimulus. A small
rise in [Ca was immediately followed by a large surge in
[Ca]. Both signals decreased in a parallel fashion to basal
values by 75 seconds.
Kinetics of the [Ca signal after KC1 and ionomycin
The kinetics of the temporal and spatial changes in [Cat ] and
[Cat concentrations after stimulation with KCI (100 mM) and
ionomycin in [Cat ]-containing medium are shown in Figure 4.
In the upper panel are the KC1-induced [Cat ÷1 increases in both
compartments. The same approach was used as shown in Figure 3.
A small increase in [Ca ] concentration was accompanied by a
large surge in the [Cat concentration. Both signals decreased
in a parallel fashion to basal values by 100 seconds. The lower
panel of Figure 4 shows the kinetics of the temporal and spatial
changes in [Ca ] and [Cat after stimulation with the Ca +
ionophore ionomycin (i0 M) in [Cat ]-containing medium.
Shown are the ionomycin-induced increases in both compart-
ments. As in the experiments with KC1, a small increase in
Nucleus
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Fig. 4. Kinetics of the temporal and spatial
changes in cytosolic [Ca +] and nuclear[Ca] calcium concentrations after stimulation
with KC1 (200 mM) (A) and ionomycin (10- M)
(B) in [Ca + '7 containing medium. The diagram
is as described in Figure 3B. A. The KCI-
induced [Ca'] increases in both
compartments. As in the experiments with Ang
II, a small increase in [Ca] was immediately
followed by a large surge in the [Ca']
concentration. Both signals decreased in a
parallel fashion to basal values by 100 seconds.
(Representative experiment out of 10). B.
Kinetics of the temporal and spatial changes in
[Ca''] and [Ca] after stimulation with the
calcium ionophore ionomycin (10 M) in[Ca]-containing medium. Shown are the
ionomycin-induced increase in both
compartments. As in the experiments with KCI,
a small increase in [Ca] was immediately
followed by a large surge in the [Ca]. Both
signals decreased in a parallel fashion to basal
values by 60 seconds (Representative
experiment out of 7).
[Ca concentration was immediately followed by a large surge
in the [Cat concentration. Both signals decreased in a parallel
fashion to basal values by 60 seconds. We also tested the effects of
the Ca channel agonist A 2386. This agonist led to a slower
increase in both [Ca ] and [Cat than did ionomycin (not
shown).
Effects of a [Ca +]-free medium and thapsigargin
Figure 5 shows the effects of EGTA and thapsigargin on the
temporal and spatial changes in [Cat and [Cat after
stimulation with Mg II in [Caj-containing medium. Adminis-
tration of Mg his shown with the vertical arrow. The approach
was the same as shown in Figure 3. Mg II alone caused both
[Cat and [Cat to surge, while [Cat reached the higher
values. Stimulation with Ang H in Ca-free medium (10 mivi
EGTA; Fig. SB) resulted in a decrease of the initial [Cat },,peak
while [Ca] values were not altered compared to control
experiments with Mg H in [Cat fl-containing medium. We next
performed the same experiment with nitrendipine, instead of
EUTA. In that experiment, a [Cat fl-containing medium was
employed. Exposure to the Ca + antagonist decreased the
[Ca] response induced by Ang II. Nitrendipine suppressed the
increase in [Cat fl,, concentration to a greater extent than the
cytosolic changes (not shown). The results with nitrendipine could
not be distinguished from those seen with EGTA. We also
examined the effects of increasing the Ca ÷ content of the
medium to 6 m. This maneuver augmented the response.
Preincubation of the vascular smooth muscle cells with thapsi-
gargin (10—6 M for 10 mm) reduced both the nuclear and [Cafl0
signal to a similar extent (Fig. SC); however, the nuclear signal
remained higher. When both intracellular calcium release and
extracellular calcium influx were prevented by the combination of
EGTA (10 mM) and thapsigargin (106 M for 10 mm), stimulation
with Mg II elicited no [Ca] signal in either the nucleus or the
cytosol (Fig. SD).
Effect of protein kinase C-inhibition on the response to Ang II
As shown in Figure 6, the protein kinase C inhibitors stauros-
porine and 117 had no effect on the angiotensin Il-mediated
increases in [CaI and [Ca],,. The format is again the same
as in Figure 3. Stimulation of the cell with Mg II is represented
by an arrow. Control conditions are shown in Figure 6A, and
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Collaborative Study Group: Proteinuria in diabetics 1689
to have 24 hour proteinuria  500 nig and diabetic retinopathy.
Patients with serum creatinine levels at baseline > 2.5 mg/dl were
excluded. Details of the inclusion and exclusion criteria of the
Captopril Study have been previously reported [2].
Patients accepted into the Captopril Study were randomized to
captopril 25 mg three times daily or an identical placebo three
times daily, as previously described [2]. Blood pressure goals were
to achieve: (1) seated office diastolic pressure < 90 mm Hg; (2)
seated office systolic blood pressure < 140 mm Hg, or if baseline
systolic blood pressure was  150 mm Hg, the goal was a decrease
of at least 10 mm Hg and a maximum systolic blood pressure of
160 mm Hg. These goals had to be achieved without the use of
calcium channel blockers or other angiotensin-converting enzyme
(ACE) inhibitors. Following randomization the patients were seen
at two weeks, one month, and every three months thereafter until
death, dialysis, or transplantation. The final status of patients with
respect to death, dialysis, or renal transplantation was determined
as of the date of administrative censoring on September 30, 1992.
Definitions used in the present study
Captopril Study patients with baseline nephrotic-range protein-
uria ( 3.5 g/24 hr) were categorized based on their final outcome
in the Captopril Study, as follows:
Remission of nephrotic-rangeproteinuria. Onset of the remission
was defined as the date when 24 hour proteinuria was first noted
to be  1 g. In addition the reduction in proteinuria had to be
sustained for at least six months and until the end of the Captopril
Study. During the period of remission the mean of all 24 hour
proteinuria values could not exceed 1.5 g. Finally, the remission of
nephrotic-range proteinuria could not be explained by decline in
renal function. That is, during the course of the Captopril Study
serum creatinine levels had to be maintained at less than a
doubling of the baseline serum creatinine level, which was the
primary study endpoint [2].
No remission of nephrotic-range proteinuria. This outcome was
defined as failure to reduce proteinuria, as described above and/or
failure to maintain serum creatinine at less than a doubling of
baseline levels.
Statistical analysis
The results were analyzed with the Statistical Analysis System
software [3}. Dichotomous baseline characteristics of the treat-
ment groups and the remission groups were compared with
Fisher's exact test [4]; continuous baseline characteristics and the
mean value of measurements over follow-up visits were compared
between the groups with Wilcoxon rank-sum test [5]. The change
from baseline to the last follow-up visit within a remission group
was assessed with Wilcoxon sign-rank tests [5]. The analyses
included all patients with nephrotic syndrome at randomization
with patients retained in their assigned treatment group regard-
less of their adherence to the treatment regimen. P value of less
than 0.05 was considered to indicate statistical significance; all
statistical tests were two-sided. Mean values are shown one
standard deviation.
Results
The 30 clinical centers of the Captopril Study entered 409
patients into the study between December, 1987, and October,
1990. Of the 409 patients entered into the Captopril Study, 108
had nephrotic-range proteinuria at baseline. The baseline clinical
Table 1. Baseline clinical characteristics of the patients in this study
who at baseline had nephrotic-range proteinuria and were then
randomly assigned to the placebo or captopril groups
Placebo groupa
(N=66) Captopril groupa(N=42)
Age 34.6 6.5 34.9 6.1
%Male 64 57
% Black 21 5
Body weight kg 75.8 17 72.6 14
Edema, % of group 52 50
Years of insulin therapy 20.5 5.4 19.7 6.0
Serum creatinine mg!dl 1.5 0.4 1.6 0.4
Creatinine clearance ml! 72 34 68 38
mm
1-GFR m1Imin' 70 33 59 31
Proteinuria g!24 hr 5.9 2.5 6.4 2.7
Glycohemoglobin % 12.3 3.3 12.5 3.5
(Normal up to 8%)
Serum cholesterol mg/dl 279 75 300 100
Serum albumin g!dl 3.3 0.5 3.3 0.5
Hematocrit % 38.1 5.9 37.6 4.9
Blood pressure mm Hg
Systolic 144 22 146 18
Diastolic 88 13 89 9
MAPC 107 14 108 11
Pulse beats!min 83.0 11 85.9 9
a No significant differences were present at baseline between the
patients with nephrotic-range proteinuria assigned to placebo or captopril,
except for % black (P = 0.025) and I-GFR (P = 0.048)b Urinary iothalamate (I) clearance (GFR) was performed in 64 of the
placebo patients and 41 of the captopril patients at baseline
C Mean arterial pressure = diastolic pressure + 1!3 (systolic pressure —
diastolicpressure)
characteristics of these patients according to assignment to the
placebo or captopril group are shown in Table 1. As can be seen,
the two groups were similar except that the percent of black
patients (P = 0.025), and the urinary iothalamate clearance (P =
0.048) were higher in the placebo group than in the captopril
group.
Table 2 shows the baseline data on the 108 patients according
to whether remission or no remission of nephrotic-range protein-
uria occurred during follow-up in the Captopril Study. As can be
seen, eight patients experienced remission, 100 patients did not.
Seven of the eight patients who achieved remission during the
Captopril Study had been assigned to captopril therapy. The
remission rate associated with captopril therapy (16.7%) was 11
times greater than that associated with placebo therapy (1.5%), P
= 0.005. Of the 16 black patients, none experienced remission of
nephrotic-range proteinuria (P = 0.602).
Figure 1 shows the sequential changes in proteinuria and Figure
2 shows the sequential changes in serum creatinine in each of the
eight Remission patients. As can be seen, each Remission patient
maintained stable or nearly stable serum creatinine levels as
proteinuria declined during the Captopril Study. The one patient
assigned to placebo who achieved remission also received ACE
inhibitor therapy for the majority of follow-up in the Captopril
Study. This occurred when the patient was removed from the
study protocol after 12 months because of inadequate control of
blood pressure. At that time therapy with an ACE inhibitor was
begun. This patient's course in relation to ACE inhibitor therapy
is shown in more detail in Figures 1 and 2.
Fig. 6. Effect of protein kinase C-inhibition on
the temporal and spatial changes in cytosolic
4 [Ca ÷ and nuclear [Ca +],, concentration in
response to Ang II. Diagram is as described in
Figure 3A. The protein kinase C inhibitor
staurosporine and H7 had no effect on the
angiotensinil-mediated increases in [Ca]
and [Ca Administration of staurosporine
had no effect on the nuclear calcium response
to Ang II (Representative experiment out of 7).
cytoplasmic value. They concluded that the lower nuclear values
observed in resting cells imply an active process to extrude [Ca]
ions from the nucleus. Ca + gradients between the nucleus and
the cytoplasm have also been described in other cell types.
Williams et al [8] used cellular fluorescence images and were able
to show that [Cat levels in the cytoplasm and nucleus of toad
smooth muscle cells were clearly different from one another.
Waybill et al [6] studied the nuclear Ca +gradients in cultured
rat hepatocytes. They found that in resting hepatocytes, [Ca]
values were lower than those in the cytoplasm. However, not all
investigators have observed a low Ca concentration in resting
cells. Himpens, Smedt and Casteels [5] studied LLC-PK1 cells and
[Ca] responses to arginine vasopressin. In these cells, no
difference in the resting [Ca] and [Ca] concentrations
were found. In previous studies with a neuronal cell line and with
pituitary cells we could also find no difference between [Ca
and [Ca] [20, 21]. Papageorgiou and Morgan [9] studied
vascular smooth muscle cells and, contrary to our results, found
that basal [Ca] exceeded the [Ca] values. These differ-
ences could be due to differences between various cell types or to
differences in the distribution of the fluorescent dye in these cells.
As described in the Methods section, we took care to possibly rule
out an artifact due to nuclear accumulation of the dye. We used
the same safeguards employed by Himpens et al [2] and therefore
believe that it is unlikely that the observed changes in [Cat ] are
due to methodological problems. In a recent report, Al-Mohanna,
Caddy and Bolsover [22] suggested that the amplification of the
[Cat ] signal is due to an enhanced sequestration of the
fluorescent dye in the cytosol, which could lead to an underesti-
mation of the [Cat However, in their experiments they
observed increased nuclear concentrations even in non-stimulated
cells, and no reversal of the cytosolic/nuclear gradient as seen by
us and others [2, 4]. Since we did not observe a differential
regulation of the [Ca] in neuronal cells [23] or in a pituitary
cell line [21] under similar conditions, we believe that the ob-
served effect of Ang II and other agonists on the [Ca4 in
VSMC is a specific feature of some cell types but not others [2, 5].
This assumption is supported by the studies of Przywara et al [11],
who also observed a different behavior of [Ca] regulation in
neuronal and non-excitable cell lines.
Stimulation of the VSMC in our study resulted in a large
increase in [Ca ] and a reversal of the cytosolic/nuclear gradi-
ent. Using a high time resolution, we could demonstrate that the
[Ca J surge was preceded by the rise in the cytosolic concen-
tration. The Ca concentration first increased in the middle of
the cytoplasm, spreading from there to the membrane and the
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nucleus. Once the Ca wave had reached the nucleus, a large
rise in [Cat was observed. These results suggest that the rise in
[Ca] triggers the [Ca] response to hormonal stimulation.
This assumption is further substantiated by our findings that an
increase in [Ca J induced by membrane depolarization also
triggered a rise in [Ca We do not know the exact mechanism
by which the rise in cytosolic calcium triggers the nuclear calcium
wave. It is possible that the local increase of calcium at the nuclear
membranes induces the activation of nuclear phospolipases which
could lead to generation of nuclear inositol phosphates with the
release of calcium from perinuclear stores. The existence of
nuclear phospholipases has been shown recently [24, 25]. An
alternative to the Ca-induced Ca release from nuclear
binding sites would be Ca trappingby the nucleus. We believe
that this latter possibility is unlikely because it has been shown
that the otherwise porous nuclear membranes are highly imper-
meable to calcium ions [6, 26].
The observation of a Ca gradient between the nucleus and
cytoplasm suggests that the nuclear membrane may have impor-
tant Ca regulatoiy functions. Several hypothesis have been put
forward to explain the mechanisms whereby extracellular hor-
mones may induce nuclear calcium response. Waybill et al
concluded that hepatocyte nuclear membranes contain Ca
permeability barriers and that Ca transport mechanisms into
the nucleus may be hormonally sensitive [6]. Himpens et al [2]
attributed the differential rise during agonist stimulation to an
influx of Ca + from perinuclear stores, and/or to a release of
[Cat ] possibly mediated by an inositol lipid-dependent mech-
anism. They concluded that the lower values in [Cat observed
in resting cells imply an active process to extrude Ca from
within the nuclear envelope. This assumption is indirectly sup-
ported by the existence of 1P3 receptors in the nucleus [12]. In
addition, Malviya, Rogue and Vincedon have demonstrated an
1P3-mediated calcium release from isolated nuclei [13]. In accord
with this hypothesis, Divecha, Banflé and Irvine [27] suggested the
existence of a discrete nuclear polyphosphoinositide signaling
system, entirely distinct from the well-known plasma membrane-
located system, which is under regulatory control by cell surface-
located receptors. However, in our experiments we could not
demonstrate an 1P3-induced Ca release using Ang II as a
PLC-coupled agonist. When the Ang IT-induced rise in [Ca
was completely prevented by removal of extracellular Ca and
emptying of intracellular stores, no [Ca ] signal could be
demonstrated. Under these conditions Ang II could still induce
G-protein dependent generation of inositol phosphates. Thus, it
appears that these substances do not mediate the hormone-
induced rise in the [Cat concentration.
Nicotera et al [14] studied isolated rat hepatocytes and found
that stimulation with adenosine-triphosphate (ATP) caused a
rapid increase in [Ca ] in these cells. They were able to inhibit
the surge in [Ca ] with a calmodulin antagonist. They sug-
gested the existence of a distinct ATP- and calmodulin-dependent
Ca uptake system in hepatocyte nuclei. We cannot rule out the
possibility that this mechanisms also takes place in VSMC. The
increase in [Cat could lead to an activation of calmodulin-
dependent mechanisms which would then trigger the [Ca]
release. However, since the protein kinase inhibitors staurospo-
rifle and H7 used in our study also act on other calmodulin-
dependent kinases, we believe that the activation of calcium/
calmodulin-dependent protein kinases is not responsible for the
[Ca] surge in vascular smooth muscle cells. Using these
inhibitors, we could also rule out that generation of protein kinase
C plays a major role in the induction of a [Ca] signal.
Pretreatment of VSMC with the PKC inhibitors staurosporine
and H7 did not influence the [Ca] signal.
Our data show that the increase in [Ca] leads to the surge
in the [Ca ] concentration. This is in accordance with the
findings by Hernandez-Cruz, Sala and Adams [7]. They found in
neuronal cells that activation of Ca + channels caused an inward
spreading of the Ca wave. The [Cat ] signalswere larger and
decayed more slowly than the [Cat concentrations. They
observed a similar cell behavior with the administration of caf-
feine. They suggested the presence of an amplification mechanism
involving Ca -induced Ca release, which may regulate nu-
clear events. However, it appears that not only the overall rise in
Ca within the cytosol influences the [Ca] signal, but also
that the source of the Ca ions plays a regulatory role. Blockade
of Ca + influx in the experiments using EGTA or with nitrendip-
me led to a greater reduction in the [Cat signal in relation to
the changes in the cytosol compared to the effects of thapsigargin.
These differences may indicate that either the pathways of Ca
entry or the subcellular distribution of the Ca ions influence
the generation of the nuclear signal. It seems that the influx of
extracellular Ca ions results in a brisker and higher Ca
response compared to the effects of Ca influx. However, we
were not able to demonstrate any significant differences in the
subcellular distribution of Ca under these different conditions.
Ang II induced a large increase in [Ca] concentration. This
increase is sufficient to induce activation of Ca-dependent
processes. Alterations in [Ca] are associated with regulation of
the cell cycle [28, 29]. Important Ca k-dependent molecular
mechanisms in the nucleus include gene transcription [29, 30] and
mitotic events [31]. Recently, Ca-dependent endonucleases,
which generate DNA breaks associated with the initiation of
mitogenesis, have been identified in the nucleus [32]. As Divecha
et al [27] have suggested, the increase in the [Ca mayplay an
important role in an intranuclear phosphoinositide signaling
leading to the activation of protein kinase C within the nucleus.
Therefore, it is likely that the observed changes in the [Ca ]
upon hormonal stimulation play a role in the induction of cell
growth. [Ca signaling by Ang II may thus be of importance in
the growth promoting activity of this vasoactive peptide. In
addition, the decrease in the [Ca] signal observed with
nitrendipine may be associated with the antiproliferative effects of
these drugs on VSMC [33].
In summary, we oberved that exposure to Ang II led to an
increase in [Ca ] concentration in VSMC. While in resting
VSMC the [Ca concentration was low compared to the
cytosol, this gradient was reversed by Ang II. We next investigated
the regulation of the [Cat ] signal and observed that the surge
in the nucleus is preceded by the rise in the cytosolic concentra-
tion. Elevation of [Cat bymeans of membrane depolarization
or Ca ionophores also triggered a [Ca] response. On
the other hand, prevention of Ca influx or emptying of the
intracellular stores diminished the [Ca] signal. A combination
of both experimental conditions led to a loss of increase in
[Ca} after Ang II stimulation and abolished the [Cat
signal. No effect on the [Cat +] signal was observed using kinase
inhibitors. These findings suggest that the Ang Il-induced Ca
signal in the nucleus of vascular smooth muscle cells is mediated
1662 HaIler et al: Vascular smooth muscle cells and nuclear Ca
by the changes in the cytosolic concentration, while the generation
of 1P3 or the activation of protein kinase C seems to play no role
in the mediation of the [Cat] effects of Mg II. It will now be
necessary to define the nuclear mechanisms which are induced
and regulated by the increase in [Cat j in order to further
characterize the mitogenic action of Mg II.
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